New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Bionoid Pharma Inc.
BINP
Shape
US Flag

OTC

2M

Drug Manufacturers - Specialty & Generic

0.04USD

Shape0.00 ( 12.90%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-96%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

92%
OverviewChart

Quote Panel

Shape
Updated June 17, 2025
1W -64.29 % 1M -53.33 % 3M -58.82 % 1Y -82.50 %

Key Metrics

Shape

  • Market Cap

    1.71M

  • Shares Outstanding

    48.76M

  • Share in Float

    20.07M

  • Dividende

    0

  • Earning Date

    No Data

  • Price Target

    0.035

  • Average Volume

    23915

  • Beta

    -4.159

  • Range

    0.022-0.448

  • Industry

    Drug Manufacturers - Specialty & Generic

  • Website

    https://bionoidpharma.com

  • Sector

    Healthcare

Fundamentals

Shape

Relative Strength

Shape

BINP

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

Analyst rating

Last analyst upgrade/downgrade

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.00
vs -0.00

Q1.23

arrow
arrow

N/A

NA
vs NA

Q2.23

arrow
arrow

N/A

0
vs NA

Q3.23

arrow
arrow

N/A

NA
vs NA

Q4.23

arrow
arrow

N/A

NA
vs -0.00

Q1.24

arrow
arrow

N/A

NA
vs NA

Q2.24

arrow
arrow

N/A

NA
vs 0

Q3.24

arrow
arrow

N/A

NA
vs NA

Q4.24

arrow
arrow

N/A

NA
vs NA

Q1.25

arrow
arrow

N/A

NA
vs NA

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-51%

6.7K  vs 13.6K

Q1.23

arrow
arrow

-53%

8.2K  vs 17.4K

Q2.23

arrow
arrow

+170%

19.9K  vs 7.4K

Q3.23

arrow
arrow

-15%

3.8K  vs 4.5K

Q4.23

arrow
arrow

-18%

5.5K  vs 6.7K

Q1.24

arrow
arrow

-42%

4.8K  vs 8.2K

Q2.24

arrow
arrow

-74%

5.1K  vs 19.9K

Q3.24

arrow
arrow

+186%

11K  vs 3.8K

Q4.24

arrow
arrow

-479%

-20941.00  vs 5.5K

Q1.25

arrow
arrow

-100%

NA  vs 4.8K

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+23%

0.23
vs -0.02

Q1.23

arrow
arrow

-3%

-0.03
vs 0.23

Q2.23

arrow
arrow

-20%

-0.20
vs -0.03

Q3.23

arrow
arrow

+2%

0.02
vs -0.20

Q4.23

arrow
arrow

+25%

0.25
vs 0.02

Q1.24

arrow
arrow

+0%

0
vs 0.25

Q2.24

arrow
arrow

+4%

0.04
vs 0

Q3.24

arrow
arrow

-4%

-0.04
vs 0.04

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News

BINP

accessnewswire.com

7 hours ago

Bionoid Pharma, Inc. Confirms Name Change to AI Maverick Intel, Inc. Following Delaware Approval
BINP

accessnewswire.com

7 hours ago

Bionoid Pharma, Inc. Rebrands as AI Maverick Intel, Inc. to Reflect Strategic Shift Toward AI-Driven Innovation
BINP

accessnewswire.com

7 hours ago

Bionoid Pharma Inc. Announces Completion of 2024 Financial Audit
BINP

accessnewswire.com

7 hours ago

Bionoid Pharma Inc. Engages Aloba, Awomolo & Partners as External Auditor for 2024 Financial Statements
BINP

accessnewswire.com

11 hours ago

Bionoid Pharma Announces Filing of OTCQB Application to Enhance Market Visibility and Liquidity
BINP

accessnewswire.com

12 hours ago

Bionoid Pharma, Inc. Announces Completion of 2022 and 2023 Financial Audits by PCAOB-Registered Firm